OCEN WALTER
ID: UNCST-2026-R024230
|
PERCEPTION OF COFFEE FARMERS ON THE DISTRIBUTION, MANAGEMENT AND EFFECTS OF DODDER WEED (CUSCUTA REFLEXA) ON COFFEE PRODUCTION IN LIRA DISTRICT, UGANDA.
REFNo: A777ES
1. To determine the farmers perception on the distribution and abundance of C. reflexa on
coffee plantations.
2. To determine coffee farmers perception on management practices of C. reflexa
3. To determine coffee farmers risks that arise from C. reflexa infestation.
|
Uganda |
2026-06-25 22:23:57 |
2029-06-25 |
Agricultural Sciences |
Non-Clinical Trial |
Degree Award |
|
Dorothy Akongo
ID: UNCST-2023-R007564
|
Evaluating Essential Services provided by the Local Governments Using Citizen Report Card
Endline Survey in Jinja, Uganda
REFNo: SS5329ES
1. To assess the citizens' knowledge and participation in the services provided by their local
government besides health.
2. To assess the community understanding and awareness of child focused health care and the right
of the child within the health care system
3. To explore health care providers’, children and community members understanding of child rights,
experiences and participation in health care received at health facilities and local government
|
Uganda |
2026-06-25 22:22:13 |
2029-06-25 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Andrew Walakira
ID: UNCST-2025-R022446
|
Combating Antimalarial Resistance: An AI-Driven Approach to Identify andPrioritize Key
Parasite Mutations
REFNo: HS7367ES
1. To use AI-driven variant prediction, structural modeling, and clinical-epidemiological data integration to identify and prioritize Plasmodium falciparum mutations associated with drug and vaccine resistance.
2. To predict the pathogenicity of mutations across the P. falciparum genome.
3. To identify mutations located in active or functionally critical regions of prioritized P. falciparum genes by applying variant effect prediction and protein structure modeling tools.
4. To link predicted pathogenic mutations with available epidemiological and clinical metadata to identify variants of public health importance, including those associated with treatment failure, disease severity, or vaccine response.
|
Uganda |
2026-06-25 22:18:53 |
2029-06-25 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Doreen Nakimuli
ID: UNCST-2021-R013668
|
Evaluation of the Uzazi Salama Project on Healthy Pregnancies and Climate Resilience among Adolescent Girls and Young Women (AGYW) in Kasese district.
REFNo: SS5254ES
Primary objective:
To generate evidence on the maternal health journey of pregnant AGYW and assess health system readiness to provide quality maternal care and access health system readiness to provide quality maternal care for AGYWs in climate affected settings.
1. To assess health system readiness to provide quality youth friendly maternal health services for adolescence girls and young women in climate affected settings
2. To explore social cultural, economic and gender-related barriers influencing AGYWs access to sexual and reproductive health and maternal health services.
3. To document AGYW experiences using a journey mapping approach.
4. To assess the impact of climate related shocks (floods, landslides, droughts etc.) on access and utilization of maternal health services.
5. To identify health system challenges affecting quality of care and influence access to and utilization of maternal health care services among adolescent girls and young women (AGYWs).
6. To generate evidence to inform co design of climate resilient interventions
|
Uganda |
2026-06-25 22:17:28 |
2029-06-25 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Julius Monday Rude
ID: UNCST-2025-R019646
|
Transmission Dynamics, Risk Factors, and Clinical Outcomes of Monkeypox Virus in Uganda from 2024 to 2025
REFNo: HS7965ES
1. To identify the risk factors of MPXV infection in Central and Western Uganda between 2024
and 2025.
2. To assess the routes of transmission of MPXV infection among adults in Central and Western
Uganda between 2024 and 2025.
3. To assess the clinical presentation of MPXV infection among hospitalized adults in Central
and Western Uganda between 2024 and 2025.
4. To assess the clinical outcomes of MPXV infection among hospitalized adults in Central and
Western Uganda between 2024 and 2025.
5. To explore the three-month post-recovery effects of MPXV infection based on experiences of
adult survivors of Mpox in communities of Central and Western Uganda between 2024 and
2025.
|
Uganda |
2026-06-25 22:15:25 |
2029-06-25 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|